Analysis of diabetes attitudes, wishes and needs in Switzerland, the Swiss DAWN2™ Study.

AIMS OF THE STUDY Swiss DAWN2™ aimed to evaluate the difficulties and unmet needs of individuals with diabetes and stakeholders, based on the assessments of diabetes care and self-management: the individual burden of disease, the perception of the quality of medical care, and the treatment satisfaction of individuals with diabetes living in the Canton of Bern. The results of the Swiss cohort were analysed and compared with the global DAWN2™ results. METHODS 239 adult individuals with diabetes were enrolled in a cross-sectional study at the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism at the University Hospital of Bern between 2015 and 2017. The participants completed validated online questionnaires regarding health-related quality of life (EQ-5D-3L) and emotional distress (PAID-5), diabetes self-care activities (SDSCA-6), treatment satisfaction (PACIC-DSF), and health-related wellbeing (WHO-5). Eligibility criteria were as follows: participants were aged >18 years, had a diagnosis of diabetes type 1 or 2 since at least 12 months and gave written informed for the participation in the present study. RESULTS When compared globally, the Swiss cohort reported a higher quality of life (77.28 ± 16.73 vs. 69.3 ± 17.9 EQ-5D-3L score, p 7% correlated to emotional distress (PAID-5, 26.08 ± 23.37 vs. 18.80 ± 17.49, p = 0.024), unfavourable eating habits (4.28 ± 2.22 vs. 4.99 ± 2.15, p = 0.034) and decreased physical activity (3.95 ± 2.16 vs. 4.72 ± 1.92, p = 0.014). Sleeping problems were most commonly reported (35.6%). In total, 28.8% of respondents completed diabetes-related educational programs. CONCLUSION In global comparison, Swiss DAWN2™ showed a lower burden of disease and yet a higher level of treatment satisfaction in patients who were treated in Switzerland. Further studies are required to assess the quality of diabetes treatment and unmet needs in patients treated outside of a tertiary care center

Kaulų mineralinio tankio (KMT) nustatymas ambulatoriniame endokrinologijos skyriuje

1. All the conducted BMD measurements by DXA (indications, technologist’s positioning and radiological analysis) among patients of the Endocrinology outpatient department of the Lithuanian University of Health Sciences have been performed according to the International Society for Clinical Densitometry (ISCD) recommendations. 2. Osteopenia was determined in 30% of research individuals and osteoporosis was determined in 70 % of research individuals (15 male patients > 70 years of age and 87 female patients). 3. 38% of research individuals are underweight (BMI <18,5 kg/m²). 4. Breast cancer patients on current aromatase inhibitor (AI) treatment meet the age, sex and pharmacologic therapy criterion regarding the International Society for Clinical Densitometry (ISCD). 5. Underweight in addition to suspicion of sarcopenia does represent a significantly high risk factor in fracture and falling risk